factual

US has no value step in drug approval

The FDA approves drugs based only on demonstrated safety and clinical benefit and never judges what the drug is worth, so a drug prolonging life by four weeks can be priced as high as one doubling survival; most other countries add a second step that ties price to value, so the U.S. has no correlation at all between the value a drug provides and its price.

factualpending

Speaker

Vincent Rajkumar

Evidence Quote

“our system is where there's no correlation at all between the value a drug provides and the price. The price is high for everything”

Source

Vincent Rajkumar on the High Price of Cancer Drugs— EconTalk
Created: 6/13/2026, 12:13:30 AM

Your notes

Loading notes...